• Sample Page
  • Home
  • Second Level
  • Investors
  • About
  • Stock Information
  • News Releases
  • SEC Filings
  • Analyst Coverage
  • Events and Presentations
  • Corporate Governance
  • Investor Contacts
  • Backgrounders
  • In the News
  • Images
  • Careers
  • Technology
  • Pipeline
  • Collaborations
  • Privacy Policy
  • Terms and Conditions of Use
  • Testtesttest
  • Pipeline

    Since our founding, Agenus has pursued our principles of targeting the immune system to fight disease. Tumors evade detection and elimination by the immune system through various mechanisms. We are using multiple strategies, as monotherapies as well as combinations, to harness the immune system to fight cancer. We will deploy our expertise and insights into immune and cancer biology to find the right combinations of antibodies including checkpoint inhibitors and other checkpoint modulators, cancer vaccines based on three proprietary platforms, and adjuvants.